- Home
- ROIV vs PSN Comparison
ROIV vs PSN Comparison
Compare ROIV & PSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- PSN
- Stock Information
- Founded
- ROIV 2014
- PSN 1944
- Country
- ROIV United Kingdom
- PSN United States
- Employees
- ROIV N/A
- PSN N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- PSN EDP Services
- Sector
- ROIV Health Care
- PSN Technology
- Exchange
- ROIV Nasdaq
- PSN Nasdaq
- Market Cap
- ROIV 8.4B
- PSN 7.8B
- IPO Year
- ROIV N/A
- PSN 2019
- Fundamental
- Price
- ROIV $10.68
- PSN $59.40
- Analyst Decision
- ROIV Strong Buy
- PSN Strong Buy
- Analyst Count
- ROIV 8
- PSN 12
- Target Price
- ROIV $17.93
- PSN $97.50
- AVG Volume (30 Days)
- ROIV 4.0M
- PSN 1.9M
- Earning Date
- ROIV 02-10-2025
- PSN 02-19-2025
- Dividend Yield
- ROIV N/A
- PSN N/A
- EPS Growth
- ROIV N/A
- PSN 49.38
- EPS
- ROIV N/A
- PSN 2.12
- Revenue
- ROIV $122,585,000.00
- PSN $6,750,576,000.00
- Revenue This Year
- ROIV $15.98
- PSN $25.71
- Revenue Next Year
- ROIV N/A
- PSN $8.83
- P/E Ratio
- ROIV N/A
- PSN $28.04
- Revenue Growth
- ROIV 140.04
- PSN 24.03
- 52 Week Low
- ROIV $9.76
- PSN $57.86
- 52 Week High
- ROIV $13.06
- PSN $114.68
- Technical
- Relative Strength Index (RSI)
- ROIV 42.58
- PSN 10.86
- Support Level
- ROIV $10.33
- PSN $72.12
- Resistance Level
- ROIV $10.86
- PSN $76.21
- Average True Range (ATR)
- ROIV 0.27
- PSN 2.60
- MACD
- ROIV 0.02
- PSN -1.36
- Stochastic Oscillator
- ROIV 29.96
- PSN 7.17
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About PSN Parsons Corporation
Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.